Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results November 3, 2025
Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results November 3, 2025
Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update August 15, 2025
Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer February 26, 2025
Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy Trial February 4, 2025
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024 May 15, 2024
